Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Cuprior |
| Active Ingredient: | Trientine tetrahydrochloride 300mg equivalent to trientine 150mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Te Arai BioFarma Limited |
| Manufacturer: | Delpharm Evreux SAS, Evreux, France |
| Product: | Ipca-Gabapentin |
| Active Ingredient: | Gabapentin 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Gabapentin |
| Active Ingredient: | Gabapentin 300mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Gabapentin |
| Active Ingredient: | Gabapentin 400mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Metronidazole Kabi |
| Active Ingredient: | Metronidazole 5mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Fresenius Kabi New Zealand Limited |
| Manufacturers: | Fresenius Kabi Deutschland GmbH, Friedberg, Germany Fresenius Kabi Polska Sp. z o.o., Kutno, Poland |
| Product: | Nugabin |
| Active Ingredient: | Gabapentin 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Nugabin |
| Active Ingredient: | Gabapentin 300mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Nugabin |
| Active Ingredient: | Gabapentin 400mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
Dated this 19th day of November 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).